Technical Analysis for ABBV - AbbVie Inc.

Grade Last Price % Change Price Change
grade F 92.68 1.82% 1.66
ABBV closed up 1.82 percent on Thursday, September 20, 2018, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ABBV trend table...

Date Alert Name Type % Chg
Sep 20 Lower Bollinger Band Walk Weakness 0.00%
Sep 20 Lower Bollinger Band Touch Weakness 0.00%
Sep 19 Below Lower BB Weakness 1.82%
Sep 19 Down 3 Days in a Row Weakness 1.82%
Sep 19 Down 4 Days in a Row Weakness 1.82%
Sep 19 Gapped Down Weakness 1.82%
Sep 19 Lower Bollinger Band Touch Weakness 1.82%
Sep 18 20 DMA Resistance Bearish 0.08%
Sep 18 Fell Below 50 DMA Bearish 0.08%
Sep 18 Expansion Pivot Sell Setup Bearish Swing Setup 0.08%

Older signals for ABBV ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
AbbVie Inc., a research-based biopharmaceutical company, engages in the discovery, development, manufacture, and sale of pharmaceutical products worldwide. Its product portfolio includes a range of adult and pediatric pharmaceuticals, including HUMIRA, a biologic therapy administered as a subcutaneous injection to treat various autoimmune diseases; Synthroid used in the treatment of hypothyroidism; AndroGel, a daily testosterone replacement therapy; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Kaletra, a prescription anti-HIV-1 medicine used with other anti-HIV-1 medications to increase the chance of treatment response in people with HIV-1; and Lupron, a product for the palliative treatment of advanced prostate cancer. The company also offers TriCor and TRILIPIX, which are fibric acid derivatives that are indicated as adjuncts to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels; Niaspan, an extended release form of niacin that is indicated as an adjunct to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels, as well as to increase HDL cholesterol levels; Synagis, which protects at-risk infants from severe respiratory disease or respiratory syncytial virus; Sevoflurane, an anesthesia product for human use; Duodopa, a levodopa-carbidopa intestinal gel used to treat advanced Parkinson's disease; and Zemplar used for the prevention and treatment of secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. The company has collaboration with Alvine Pharmaceuticals, Inc. to develop a oral treatment for patients with celiac disease. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois. As of January 01, 2013.AbbVie Inc. operates independently of Abbott Laboratories.
Is ABBV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 125.86
52 Week Low 82.6137
Average Volume 5,715,549
200-Day Moving Average 100.536
50-Day Moving Average 94.8608
20-Day Moving Average 95.0885
10-Day Moving Average 93.81
Average True Range 1.9952
ADX 18.1
+DI 18.7317
-DI 32.5947
Chandelier Exit (Long, 3 ATRs ) 92.7144
Chandelier Exit (Short, 3 ATRs ) 96.3856
Upper Bollinger Band 98.9586
Lower Bollinger Band 91.2184
Percent B (%b) 0.19
BandWidth 8.139996
MACD Line -0.7956
MACD Signal Line -0.4353
MACD Histogram -0.3603
Fundamentals Value
Market Cap 147.75 Billion
Num Shares 1.59 Billion
EPS 4.07
Price-to-Earnings (P/E) Ratio 22.77
Price-to-Sales 5.35
Price-to-Book 23.76
PEG Ratio 1.00
Dividend 2.56
Dividend Yield 2.76%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 96.43
Resistance 3 (R3) 96.16 94.64 95.81
Resistance 2 (R2) 94.64 93.69 94.78 95.60
Resistance 1 (R1) 93.66 93.10 94.15 93.93 95.39
Pivot Point 92.14 92.14 92.39 92.28 92.14
Support 1 (S1) 91.16 91.19 91.65 91.43 89.97
Support 2 (S2) 89.64 90.60 89.78 89.76
Support 3 (S3) 88.66 89.64 89.56
Support 4 (S4) 88.93